StockData
Aura Biosciences, Inc. logo

Aura Biosciences, Inc. (AURA) stock

AURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$7.11−0.50 (-6.57%)

Close on Nov 12, 2026Market cap $737.34MP/E –Yield –

Aura Biosciences statistics

66 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 29, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$737.34M
$280.48M
Enterprise Value
$695.67M
$148.62M
PB Ratio
2.57
2.05
P/TBV Ratio
2.57
2.29

Share statisticsIndustry

Shares Change (YoY)
52.0%
10.9%
Shares Change (QoQ)
0.45%
0.48%
Float
96M
49M
Shares Held by Insiders
7.38%
12.1%
Shares Held by Institutions
94.8%
56.4%

Short sellingIndustry

Short Interest
10M
–
Short Interest Change
-3.87%
-0.76%
Short % of Float
10.9%
9.06%
Short % of Shares Outstanding
10.1%
6.30%
Days to Cover
13.67
5.13

Stock price statisticsIndustry

52-Week High
$9.54
–
52-Week Low
$4.73
–
20-Day Moving Average
$6.57
–
50-Day Moving Average
$6.55
–
200-Day Moving Average
$6.78
–
Average True Range (14)
$0.40
–
Price Change (1 Week)
12.1%
1.51%
Price Change (1 Month)
15.2%
-2.37%
Price Change (3 Months)
-7.54%
-21.1%
Price Change (6 Months)
-10.9%
-22.8%
Price Change (YTD)
30.5%
-22.6%
Price Change (1 Year)
25.6%
-21.0%
Price Change (3 Years)
-8.26%
-24.8%
Price Change (5 Years)
-59.3%
-76.9%
Average Volume (10 Days)
823,360
–
Average Volume (20 Days)
811,384
–
Average Volume (90 Days)
779,577
–
Relative Volume
1.29
0.80
Relative Strength Index (14)
57.3
44.7
Volatility (1 Year)
58.4%
80.2%
Beta (5 Years)
1.36
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-61.7%
-51.3%
Return on Assets (ROA)
-53.5%
-40.7%
Return on Invested Capital (ROIC)
-64.7%
-32.9%
Return on Capital Employed (ROCE)
-48.4%
-38.1%

Financial positionIndustry

Current Ratio
14.21
3.31
Quick Ratio
1.95
2.41

EfficiencyIndustry

Profits Per Employee
-$1.21M
-$683.67K
Employee Count
113
75
WACC
11.7%
10.0%

Income statement (TTM)Industry

Operating Income
-$145.23M
-$20.99M
Pretax Income
-$136.85M
-$13.23M
Net Income
-$136.95M
-$21.61M
EBITDA
-$145.23M
-$16.85M
EPS (Diluted)
-$1.65
-$0.75

Balance sheetIndustry

Net Cash (Debt)
$41.67M
$16.98M
Net Cash Per Share
$0.40
$0.72
Equity (Book Value)
$287.43M
$52.68M
Book Value Per Share
$2.77
$1.50
Tangible Book Value
$287.43M
$26.74M
Working Capital
$281.76M
$78.52M

Cash flow (TTM)Industry

Operating Cash Flow
-$109.30M
-$12.27M
Capital Expenditures
-$379.00K
-$944.00K
Free Cash Flow
-$109.68M
-$18.20M
FCF Per Share
-$1.06
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-18.6%
-21.0%
FCF Yield
-14.9%
-9.44%

Taxes and interestIndustry

Income Tax
$93.00K
$74.00K

Scores and fair valueIndustry

Altman Z-Score
9.92
0.26
Piotroski F-Score
2
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodAURAS&P 500DifferenceAURA per yearS&P 500 per year
1 month+8.7%-2.7%+11.4 pts
3 months-8.3%-1.7%−6.5 pts
Year to date+30.5%+11.9%+18.6 pts
1 year+27.6%+12.0%+15.7 pts
3 years-7.5%+78.2%−85.7 pts-2.6%+21.2%
5 years-59.3%+73.2%−132.6 pts-16.5%+11.6%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

10M AURA shares were sold short on Oct 30, 2026, down 3.9% from the previous report, or 10.89% of the shares available to trade. At recent volumes it would take 13.7 days to buy them back. Over the last 20 sessions, 55.3% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202610,464,215-3.9%765,41713.7
Oct 15, 202610,885,962+5.0%1,023,78710.6
Sep 30, 202610,366,122+47.0%1,122,5559.2
Sep 15, 20267,049,973+13.6%604,73011.7
Aug 31, 20266,203,498+0.7%972,2306.4
Aug 14, 20266,158,945-3.1%622,0799.9
Jul 31, 20266,358,049+13.4%344,39418.5
Jul 15, 20265,608,945-19.1%692,7448.1
Jun 30, 20266,932,229+28.7%742,1979.3
Jun 15, 20265,386,870+43.2%521,87710.3
May 29, 20263,762,979+19.2%496,4367.6
May 15, 20263,156,446+44.0%1,134,9372.8

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?